0
0

Sickle Cell Care Expansion Act of 2023

2/16/2024, 9:08 PM

Summary of Bill S 1423

The Sickle Cell Care Expansion Act of 2023, also known as Bill 118 s 1423, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to improve access to care and treatment for individuals with sickle cell disease, a genetic blood disorder that affects red blood cells.

The bill proposes several key provisions to achieve this goal. Firstly, it aims to increase funding for research into sickle cell disease, with a focus on developing new treatments and improving existing ones. This would help to advance our understanding of the disease and ultimately improve outcomes for patients.

Additionally, the bill seeks to expand access to comprehensive care for individuals with sickle cell disease, including preventive services, pain management, and mental health support. This would help to address the complex needs of patients with this condition and improve their overall quality of life. Furthermore, the bill includes provisions to improve education and awareness of sickle cell disease among healthcare providers and the general public. This would help to ensure that individuals with the disease receive timely and appropriate care, and that they are able to advocate for themselves effectively. Overall, the Sickle Cell Care Expansion Act of 2023 represents a significant step towards improving care and treatment for individuals with sickle cell disease. By increasing funding for research, expanding access to comprehensive care, and improving education and awareness, this bill has the potential to make a real difference in the lives of those affected by this challenging condition.

Congressional Summary of S 1423

Sickle Cell Care Expansion Act of 2023

This bill establishes programs to increase treatment and other services for populations with sickle cell disease. Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.

Specifically, the Department of Health and Human Services (HHS) must award grants to federally qualified health centers, community-based organizations, or other nonprofits that treat or otherwise support populations with sickle cell disease for education and advocacy programs concerning the disease. HHS must also award grants to nonprofits, including hospitals or institutions of higher education, that provide comprehensive care to populations with sickle cell disease for programs to support the transition from pediatric to adult care for patients with the disease.

Additionally, the Health Resources and Services Administration must establish a program to provide scholarships or student loan repayment awards to individuals who commit to engage in clinical practice or research related to sickle cell disease for a period of obligated service as physicians.

Current Status of Bill S 1423

Bill S 1423 is currently in the status of Bill Introduced since May 3, 2023. Bill S 1423 was introduced during Congress 118 and was introduced to the Senate on May 3, 2023.  Bill S 1423's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of May 3, 2023

Bipartisan Support of Bill S 1423

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
4
Democrat Cosponsors
4
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 1423

Primary Policy Focus

Health

Potential Impact Areas

- Blood and blood diseases
- Community life and organization
- Congressional oversight
- Government information and archives
- Health personnel
- Hereditary and development disorders
- Higher education
- Medical education
- Student aid and college costs

Alternate Title(s) of Bill S 1423

Sickle Cell Care Expansion Act of 2023
Sickle Cell Care Expansion Act of 2023
A bill to amend the Public Health Service Act to authorize a scholarship and loan repayment program to incentivize physicians to enter into the field of sickle cell disease research, treatment, and patient care, and for other purposes.

Comments

Latest Bills

To amend the Internal Revenue Code of 1986 to modify certain percentage depletion rules with respect to oil and gas wells.
Bill HR 8034April 7, 2026
To prohibit preferential screening for Members of Congress at airports, and for other purposes.
Bill HR 8049April 7, 2026
To expand credentialed, personalized financial and housing counseling to members of the Armed Forces serving on active duty or transitioning from service, and for other purposes.
Bill HR 8056April 7, 2026
To amend the FISA Amendments Act of 2008 to extend the authorities of title VII of the Foreign Intelligence Surveillance Act of 1978 through October 20, 2027, and for other purposes.
Bill HR 8035April 7, 2026
To amend title XVIII of the Social Security Act to ensure equitable payment for, and preserve Medicare beneficiary access to, cancer treatments under the Medicare hospital outpatient prospective payment system.
Bill HR 8032April 7, 2026
To amend title XLI of the FAST Act to lower the cost estimate threshold relating to eligibility of infrastructure projects for certain permitting processes, and for other purposes.
Bill HR 8003April 7, 2026
To amend the Defense Production Act of 1950 to limit eligibility for assistance, increase monetary penalties, establish fraud risk management processes, and for other purposes.
Bill HR 8030April 7, 2026
To prohibit a road construction project in the White River National Forest in the State of Colorado, and for other purposes.
Bill HR 8061April 7, 2026
To establish a reserve fund for the United States Secret Service, and for other purposes.
Bill HR 8058April 7, 2026
To amend title 38, United States Code, to require that a sterile processing technician of the Veterans Health Administration holds an appropriate professional certification, and for other purposes.
Bill HR 8052April 7, 2026
Sickle Cell Care Expansion Act of 2023
Bill HR 3100December 15, 2023